Loading...
Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
BACKGROUND: Lung stereotactic ablative radiotherapy (SABR) is associated with low morbidity, however there is an increased risk of treatment-related toxicity in tumors directly abutting or invading the proximal bronchial tree, termed ‘ultra-central’ tumors. As there is no consensus regarding the opt...
Saved in:
| Published in: | Radiat Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880025/ https://ncbi.nlm.nih.gov/pubmed/29606150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-018-1001-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|